Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia”

119 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 119 results

Early research (Phase 1)Ended earlyNCT04762186
What this trial is testing

Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19

Who this might be right for
Moderate COVID-19-infection
Universitätsklinikum Köln 1
Early research (Phase 1)UnknownNCT04474340
What this trial is testing

COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients

Who this might be right for
Moderate COVID-19 Pneumonia, Severe COVID-19 PneumoniaPneumonia, Viral
Ministry of Health, Kuwait 300
Testing effectiveness (Phase 2)Ended earlyNCT05156671
What this trial is testing

Adrecizumab (HAM8101) to Improve Prognosis and Outcomes in COVID-19 Trial

Who this might be right for
COVID-19
Universitätsklinikum Hamburg-Eppendorf 16
Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Testing effectiveness (Phase 2)UnknownNCT04622865
What this trial is testing

Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19

Who this might be right for
SARS-CoV 2COVID-19Coronavirus Disease 2019
AB Science 200
Testing effectiveness (Phase 2)WithdrawnNCT04561180
What this trial is testing

Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Evergreen Therapeutics, Inc.
Early research (Phase 1)WithdrawnNCT04490486
What this trial is testing

Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeCorona Virus Infection
Joshua M Hare
Not applicableWithdrawnNCT04466657
What this trial is testing

Antioxidant Therapy for COVID-19 Study

Who this might be right for
Covid-19
Obafemi Awolowo University
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Large-scale testing (Phase 3)Study completedNCT04501783
What this trial is testing

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
R-Pharm 168
Testing effectiveness (Phase 2)Ended earlyNCT05195749
What this trial is testing

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

Who this might be right for
COVID-19
101 Therapeutics 3
Testing effectiveness (Phase 2)UnknownNCT04760821
What this trial is testing

Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19

Who this might be right for
Acute Respiratory Distress SyndromeCovid19Myocardial Injury
Ministry of Health, Brazil 80
Testing effectiveness (Phase 2)Study completedNCT04932941
What this trial is testing

MP1032 Treatment in Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19
MetrioPharm AG 132
Large-scale testing (Phase 3)Ended earlyNCT04516811
What this trial is testing

Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19SARS-CoV-2 InfectionSevere Acute Respiratory Syndrome Coronavirus 2
South African National Blood Service 102
Post-approval studies (Phase 4)UnknownNCT04359316
What this trial is testing

Azithromycin in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Testing effectiveness (Phase 2)WithdrawnNCT04355676
What this trial is testing

Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19

Who this might be right for
Coronavirus Infection
Karyopharm Therapeutics Inc
Testing effectiveness (Phase 2)UnknownNCT04321993
What this trial is testing

Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients

Who this might be right for
COVID-19
Lisa Barrett 363
Testing effectiveness (Phase 2)UnknownNCT04977960
What this trial is testing

Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19

Who this might be right for
COVID-19 Acute Respiratory Distress Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 180
Large-scale testing (Phase 3)Ended earlyNCT04403685
What this trial is testing

Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers

Who this might be right for
COVIDSARS PneumoniaCytokine Release Syndrome
Beneficência Portuguesa de São Paulo 129
Large-scale testing (Phase 3)UnknownNCT04952805
What this trial is testing

Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.

Who this might be right for
Covid19
Toscana Life Sciences Sviluppo s.r.l. 800
Load More Results